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Abstract

National CMV Foundation

One in 150 infants is born with cytomegalovirus (CMV) and one in 750 will have lifelong disabilities due to CMV. Even though congenital CMV is the
leading viral cause of congenital disabilities and the leading non-genetic cause of childhood hearing loss, most adults have never heard of it. Data from
the 2015 and 2016 HealthStylesTM surveys were analyzed and compared to data from similar studies and show an awareness rate of 7% for U.S. adults
(5% for men and 9% for women), a statistically significant decrease from 2005 and 2010 HealthStylesTM surveys. Predictors of awareness include
gender and education level. The presence of a child ages 0–5 in the household does not increase the chance that an adult in the household is aware of
CMV. CMV is a large public health burden and further research needs to be focused on awareness and prevention of the negative sequela associated
with congenital CMV.
Acronyms: CDC = Centers for Disease Control and Prevention, CMV = Cytomegalovirus, IOM = Institutes of Medicine (now known as National Academies of Sciences,
Engineering, and Medicine), STD = Sexually Transmitted Disease
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Introduction
Cytomegalovirus (CMV) is a member of the herpes family
of viruses, spread through bodily fluids including saliva,
blood, genital secretions, urine, and breast milk. Ninety
percent of the U.S. population has had CMV by the time
they are 80 years old and most do not experience any
symptoms (Fowler & Boppana, 2006; Staras, Dollard, &
Radford, 2006).
Nonetheless, CMV has a very heavy disability burden
when acquired congenitally. It is the leading cause of
non-genetic hearing loss (Fowler & Boppana, 2006) with
15–20% of bilateral moderate to profound sensorineural
hearing loss caused by CMV (Grosse, Ross, & Dollard,
2008). Congenital CMV also causes mental retardation,
cerebral palsy, and many other disabilities (Dollard, Grosse,
& Ross, 2007). Approximately 0.7% of infants are estimated
to be born with congenital CMV in the United States,
leading to 30,000 annual cases. About 90% of these babies
are referred to as asymptomatic because there are no
clinically apparent symptoms of the infection, and 10%
are referred to as symptomatic because there are obvious
clinical abnormalities (Boppana, Ross, & Fowler, 2013).
Approximately 6,000, or one in five of those newborns
with congenital infection will go on to develop permanent
disabilities such as microcephaly, hearing loss, vision loss,
cerebral palsy, seizure disorders, or cognitive impairment
(Cannon, 2009).

According to the Institute of Medicine (IOM, 2000), the cost
of medical and educational care for children with disabilities
known to be due to congenital CMV in the United States
is $1.9 billion per year. Given such high costs associated
with congenital CMV, the IOM identified the development
of a vaccine to prevent congenital CMV as a top priority.
However, a vaccine appears to be years, if not decades
away (Adler & Nigro, 2013).
There is no FDA-approved treatment for congenital CMV,
but recent research by Kimberlin et al. (2015) on the use
of Valganciclovir to treat symptomatic congenital CMV
infections is promising. Even if an approved treatment or a
vaccine can be developed and becomes widely available,
the best alternative for reducing the incidence of congenital
CMV at the present time appears to be more widespread
use of basic hygiene practices among pregnant women to
avoid transmission via saliva or urine from young children
(Adler & Nigro, 2013; Pass & Anderson, 2014; Swanson
& Schleiss, 2013). The first step in improving hygiene
practices that will likely lead to reducing the incidence
of congenital CMV, is ensuring that the general public,
especially men and women of childbearing age, knows
about the existence and consequences of CMV.
This paper presents previously unpublished findings from
the 2015 and 2016 HealthStylesTM surveys about the
awareness of CMV among adults in the United States. It
uses the results of analyses to identify further research
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needs and guidance for policymakers and public health
programs on where to focus efforts to increase awareness
of congenital CMV.
CMV Transmission
Pregnant women are most likely to contract CMV from
young children and intimate partners (Fowler & Pass,
2006). CMV is transmitted from young children to pregnant
women through urine or saliva during diaper changes,
sharing of eating utensils, or exchanging saliva when
kissing. CMV can also be sexually transmitted.
Johnson, Anderson, and Pass (2012) documented
a number of factors associated with acquisition of
CMV infections, often referred to in the literature as
seroconversion. Seroconversion is when a person
transitions from seronegative (has never had a CMV
infection) to seropositive or seroconverted (has had a CMV
infection). Low income pregnant women have almost three
times the incidence (6.8%) of CMV infection compared
to middle income pregnant women (2.5%). Thirty-seven
percent of women in sexually transmitted disease (STD)
clinics and 7.9–10% of daycare workers contract CMV
infections each year. At the highest risk for CMV infection
are parents of children who have recently had an active
CMV infection and have CMV in their saliva, urine, and
other bodily fluids that could be passed to another person
(often referred to as shedding the virus).
CMV Prevention
Stowell, et al. (2014) found that while the CMV virus
can live for up to 15 minutes on hard plastic and up to 5
minutes on crackers, no viable virus was recovered after
washing hands with soap, sanitizer, or even just with water.
The Centers for Disease Control and Prevention (CDC)
recommend that an effective way of reducing exposure
to and the incidence of CMV infection is by “regular hand
washing, particularly after changing diapers.” (CDC, n.d.).
Research studies have demonstrated that this and other
preventative steps are effective. For example, Adler and
Nigro (2013) found that only 3% (one of 37) of CMVseronegative pregnant women with an infected young child
who were educated about using simple hygiene practices
in their daily routines seroconverted to CMV during
pregnancy, while 42% (65 of 154 women) of pregnant
women who were not educated seroconverted.
Other studies support the implementation of preventative
hygienic precautions. Revello et al. (2015) found that
only 1.2% of women who were given hygiene information
and prospectively tested until delivery acquired a CMV
infection, compared to 7.6% in a comparison group that
were neither tested nor informed about CMV during
pregnancy. Importantly, 93% of these women felt hygiene
recommendations were worth suggesting to all pregnant
women at risk for infection. In an earlier study, VauloupFellous et al. (2009) found, for 2,595 seronegative
women, that the incidence of maternal CMV conversion
was reduced from 0.035% per woman-week to 0.008%
per woman-week (P = .0005) following an educational

intervention. Women were less than 25% as likely to
acquire a CMV infection when the woman and her partner
were given detailed information on preventative hygienic
measures verbally and in writing.
Previous Assessments of CMV Awareness
The public health impact of congenital CMV infection is
substantial and under-recognized. (Swanson & Schleiss,
2013). While congenital CMV is one of the most common
causes of congenitally acquired childhood disabilities and is
preventable, most women of childbearing age have never
heard of it (Cannon, 2009; Jeon et al., 2006; Ross, Victor,
Sumartojo, & Cannon, 2008).
Three surveys of public CMV awareness in the United
States have been conducted in the past decade. Jeon
et al. (2006) surveyed 643 women at seven geographic
locations (Atlanta, GA; Birmingham, AL; Cleveland, OH;
Provo, UT; Richmond, VA; Chicago, IL; and Houston, TX)
and found that only 142, or 22%, of women surveyed had
heard of congenital CMV. Women’s awareness statistically
significantly increased with higher levels of education, older
age, and previous employment in a healthcare profession.
When multiple regression analyses were used to adjust for
other covariates, age no longer predicted awareness, but
higher levels of education (high-school diploma or less,
OR = 1.0; some college, OR = 1.5; bachelor’s degree or
more, OR = 2.1; p = .03) and employment in a healthcare
profession (no, OR = 1.0; yes, OR = 6.8, p < .0001)
remained statistically significantly related. The study found
no statistically significant differences by income, race and
ethnicity, or between women who had been pregnant and
who had never been pregnant. The study also found that
employment in a daycare setting did not impact awareness
(no, 21%, OR = 1.0; yes, 27%, OR = 1.4; p = .18).
Jeon et al. (2006) also found that most women, even those
who had heard of CMV, could not identify modes of CMV
transmission or prevention and 23% (83 of 137) incorrectly
stated that CMV could be prevented by avoiding cat litter.
One strength of the study was that it compared awareness
about CMV with awareness about other birth defects
and childhood illnesses and first reported the disparity
between awareness and incidence rates of various
childhood conditions. Jeon et al. (2006) noted that 53% of
respondents were aware of congenital rubella syndrome,
which had been eradicated in the United States, compared
to 22% who were aware of CMV. Comparing CMV
awareness with other diseases and conditions provides
context for the results and makes them more relevant for
decision- and policymakers.
A limitation of Jeon et al.’s (2006) study was that
participants were recruited from pediatric outpatient clinic
waiting rooms (4 sites), an obstetrics/gynecology clinic,
a university’s student center, and medical students and
support staff in a hospital. The fact that the survey was a
convenience sample administered in mainly healthcare
settings means that it may not be representative of all
women in the United States (for example, women with
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knowledge about CMV were likely oversampled given that
the survey was conducted in health care settings).
Awareness of congenital CMV was also queried in the 2005
and 2010 HealthStylesTM survey, a subset of a consumer
mail survey of U.S. adults over 18 years of age commonly
used by the CDC for public health planning (Ross et
al., 2008). HealthStylesTM surveys oversample certain
demographic groups to enable more precise estimates
about responses from people in those groups, but then
the data are weighted to create a nationally representative
sample with respect to age, sex, race/ethnicity, income,
and household size. In the 2005 HealthStylesTM survey,
2,656 females and 2,163 males responded to four CMVrelated questions, but the analyses reported by Ross et
al. (2008) only focused on women because they are at
risk for transmitting CMV to an unborn child. The potential
role of a sexual partner in spreading CMV to a pregnant
woman was not considered. Four questions asked whether
participants had heard of CMV, where they learned about
CMV, knowledge about the effects of CMV, and whether
they would willingly adopt measures to prevent CMV while
pregnant. The survey also collected demographic variables
including sex, age, income, race and ethnicity, level of
education, and household size.
Ross et al. (2008) reported that 14% of women had heard
of CMV, and consistent with Jeon et al. (2006), knowledge
increased with level of education (did not graduate high
school, 10%, OR = 1.0; graduated high school, 6%, OR =
0.6; attended college, 13%, OR = 1.4; graduated college,
22%, OR = 2.6; 5–8 years of graduate school, 23%, OR =
2.7; p < 0.001). Knowledge also increased with household
income, but not when other covariates were controlled
using multiple regression analyses.
Ross et al. (2008) also found that the preventative
hygiene measures previously recommended by the CDC
were judged to be easy to adopt by a large majority of
participants, regardless of whether participants had heard
of CMV. For example, 90% reported that washing hands
would be very easy to adopt and 65% reported that it
would be easy to adopt the recommendation to not share
eating utensils with a young child. Fewer participants, 48%,
reported that not kissing a young child on the mouth would
be very easy, but 20% reported it would be somewhat easy.
The 2010 HealthStylesTM survey, with a sample of 2,181
women and 2,003 men, showed 13% of women and 7% of
men had heard of CMV (Cannon et al., 2012). As with the
2005 survey, Cannon et al. (2012) only reported analysis
results for women. Congenital CMV awareness varied by
age, race/ethnicity, educational attainment, geographic
region, and household income, with the strongest
association between CMV awareness and the educational
level of the respondent, even though awareness among
women with post-graduate education was only 21%.
Because only linear trend data were reported, odds
ratios cannot be compared to previous surveys. The
2010 survey did not repeat questions related to the ease

of implementing the CDC’s recommended precautions,
but added questions regarding the number of times
women with children under age 19 engaged in risk and
preventative behaviors while their youngest child was still
in diapers. The study found that both risk and preventative
behaviors are common (e.g., 69% of women reported
kissing young children on the lips, 42% reported sharing
utensils with young children, 95% reported washing hands
after diaper changing, and 65% reported washing hands
after wiping a child’s nose).
Recently, Thackeray and Magnusson (2016) assessed
childcare provider awareness of CMV and other infectious
diseases by asking a random sample of licensed family
and residential childcare providers in Utah to complete a
29-item questionnaire on awareness of CMV and other
infectious diseases. The study focused on awareness
as well as knowledge of how to prevent diseases in
childcare settings. Thackeray and Magnusson found that
18.5% of 306 respondent childcare providers had heard
of CMV. For comparison, 99.4% were aware of influenza,
67.2% of giardia, 24.9% of toxoplasmosis, and 23.2% of
enterovirus. Because childcare providers are at higher risk
for CMV infections and may be serving infants and young
children with asymptomatic CMV infections, it is particularly
important that they are aware of CMV (Thackeray &
Magnusson, 2015). While targeted information has been
provided to licensed childcare providers in Utah (Utah
Department of Health, n.d.), public awareness efforts
should reach both licensed and unlicensed childcare
providers everywhere.
Finally, a 2014 survey of congenital CMV knowledge
among medical students (Baer, McBride, Caviness &
Demmler-Harrision, 2014) found that 34% of first year
medical students and 100% of second through fourth year
medical students at Baylor University, were somewhat
or very familiar with CMV. Self-reported awareness by
these students who were enrolled at a university with a
history of significant research conducted on congenital
CMV, was confirmed based on second through fourth year
students’ knowledge of modes of CMV transmission and
signs and symptoms of CMV. Similar studies have not
been conducted at other institutions where CMV research
is not a priority. Consistent with results from the 2005
HealthStylesTM survey of CMV awareness completed by
the CDC showing correlation with employment in a medical
field, students’ awareness in this study was strongly
correlated with level of medical education (p <.0001).
In summary, CMV awareness among the general
population is low and appears to be declining over time.
While there are some predictors of CMV awareness, even
those factors only raise CMV awareness levels among the
general population slightly. This article uses data from more
recent HealthStylesTM surveys to evaluate whether CMV
awareness rates are declining and discusses potential
research and public health policy mechanisms that could
be used to increase awareness about CMV.
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CMV Awareness Programs
Recently, there have been a number of public health
efforts to increase awareness about CMV. In 2013, the
Utah Legislature unanimously passed the first CMV public
health initiative law (McVicar, 2014). Utah’s law mandates
that the Utah Department of Health implement a public
health education campaign to inform women who are
pregnant or might become pregnant about CMV, the risks
associated with CMV, and the recommended prevention
measures. The law also mandates an education campaign
for medical and child-care professionals. The charge for
implementation was given to the Early Hearing Detection
and Intervention (EHDI) program within the state’s
Department of Health.
Utah’s law was the first of its kind and appears to have
spurred action in several other states. As of 2015, five
states had enacted CMV laws (Doutre, 2015). Based on
enactment of these laws, multiple programs have been
initiated by state Departments of Health to educate women
about CMV. In addition to legislatively-mandated public
awareness programs, other EHDI programs are leading
efforts to raise awareness of CMV (Mirizzi et al, 2015).
A number of non-profit organizations are also working to
raise awareness of CMV. The National CMV Foundation
(2015) was founded when four non-profit CMV
organizations joined forces with an aim to “empower
women, parents, families, and local community networks
through grassroots engagement to facilitate conversations
about CMV and to champion the cause against congenital
CMV” (http://www.nationalcmv.org).
As public health programs and non-profit organizations
work to increase awareness about CMV, it is important to
document how people’s awareness of CMV is changing.
Such efforts will help focus educational efforts, identify
factors that influence likelihood of CMV awareness,
evaluate effectiveness of approaches to increasing CMV
awareness, and determine areas of need and opportunity
for the greatest impact. This article combines results from
the previously-reported 2005 and 2010 HealthStylesTM
survey data (Ross et al., 2008; Cannon et al., 2012) with
previously unreported analyses from the 2015 and 2016
HealthStylesTM survey data to examine whether public
awareness about CMV is increasing, decreasing, or staying
the same.
Methodology
Data Set
The National CMV Foundation contracted with Porter
Novelli to include the same awareness question about CMV
in the 2015 and 2016 Summer HealthStylesTM surveys
that had been asked in the 2005 and 2010 versions of
the survey. Have you heard of the following: congenital
rubella syndrome, beta strep (Group B strep), HIV/AIDS,
congenital cytomegalovirus (CMV), Down syndrome,
sudden infant death syndrome (SIDS), fetal alcohol

syndrome, autism, spina bifida, congenital toxoplasmosis,
and parvovirus B19? The resulting data were provided to
Utah State University for analysis. Both data sets were
collected by Porter Novelli Public Services via GfK’s
KnowledgePanel® (a national, probability-based panel
that is representative of the entire U.S. population). GfK’s
KnowledgePanel® consists of 55,000 panel members who
are randomly recruited from a sample frame of residential
addresses “including households that: have unlisted
telephone numbers, do not have landline telephones, are
cell phone only, do not have current internet access, and do
not have devices to access the internet” (GfK, 2013). GfK
provides household without phone and or internet with a
laptop computer and internet access. The panel of 55,000
is continuously replenished and respondents for individual
surveys are selected from the larger panel to ensure a
representative sample.
The summer 2015 HealthStylesTM survey was conducted
from June 11 to June 29, 2015 with 4,127 adults completing
the survey (a response rate of 67%). All respondents
received compensation for completing the survey in the
form of cash-equivalent reward points worth approximately
$10. Respondents with incomplete responses (who did not
answer at least half of the questions, n = 7) and speeders
(who completed the survey in 7 minutes or less, n = 33)
were removed from the data.
The summer 2016 survey was conducted from June 24
to July 11, 2016 using the same procedures and had a
response rate of 68% with 4,203 of 6,166 adults completing
the survey. Participants received the same compensation
as that provided in 2015. Incomplete (n = 10) and speeder
(n = 39) responses were removed from the data set.
Participants responded to a question asking if they had
heard of the following conditions: congenital rubella
syndrome, beta strep (Group B strep), HIV/AIDS,
congenital cytomegalovirus (CMV), Down syndrome,
sudden infant death syndrome (SIDS), fetal alcohol
syndrome, autism, spina bifida, congenital toxoplasmosis,
and parvovirus B19. The question asked for each condition
was “Have you heard of [condition]?”. Response choices
were Yes, No, or the participant could refuse to answer the
question. Respondents’ awareness of CMV compared to
awareness of other conditions provides context to policy
and decision makers and allows for analysis of awareness
compared to disease burden, making a case for the
potential impact of CMV awareness initiatives.
Data were also available about each respondent’s race/
ethnicity, gender, zip code, whether the respondent
currently had children under age 18, ages of the
respondent’s three youngest children, age, education
(highest degree received and categorical), household size,
household income, marital status, metro status (metro or
non-metro), census region, employment status, housing
status (own, rent, or occupied without payment of rent), and
state of residence. Weights were provided so that survey
responses could be matched to U.S. Current Population
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Survey proportions using 9 factors: gender, age, household
income, race/ethnicity, household size, education, census
region, metro status, and prior internet access.
Data Analysis
An analysis of descriptive statistics was conducted for all
study variables for both the 2015 and 2016 HealthStylesTM
data using the R statistical software program. Rates of
awareness for CMV were computed using data weighted
for representativeness and stratified by demographic
characteristics. In addition, CMV awareness rates were
compared to awareness rates for other conditions queried
in the survey.
A total of five logistic regression models were used to
assess both the trend and characteristics related to CMV
awareness. One model tests the trend across time,
using the year as the independent variable. Two logistic
regression models per year were used to determine
the association of demographic conditions with CMV
awareness, where CMV awareness was the binary
outcome for both models. The first model examined basic
demographic predictor variables: age, race, gender,
education, and household income. The second model
added two additional predictor variables to the model

to examine parenthood and age of children: household
presence of children under ages 0–1 and household
presence of children ages 2–5. These variables were
chosen based on the relativity of CMV awareness to
families experiencing pregnancy and the increased risk of
acquiring CMV from a young child.
Results
The 2015 and 2016 HealthStylesTM CMV awareness rates
are 6.79% and 6.70% in the overall U.S. population when
weighted for representativeness. Awareness rates for
all levels of the various demographic characteristics are
similarly low as shown in Table 1. Females have a higher
rate of awareness than males (9.08% and 9.17% in 2015
and 2016 compared to 5.72% and 4.92%), but the number
of females reporting awareness of congenital CMV has
decreased from 14% and 13% in 2005 and 2010. Figure
1 is a summary of HealthStylesTM survey data from 2005,
2010, 2015 and 2016, showing a decrease over 11 years
for women from 14% to 9% and for men a decrease from
2010 to 2016 from 7% to 5%. Data from the 2005 survey
were not reported for men.

Table 1. U.S. Congenital Cytomegalovirus Awareness By Demographic Characteristics, 2015 and 2016
2015 (N = 4121)

2016 (N = 4197)

% (n)

% (n)

6.79% (310)

6.70% (300)

Male
Female

5.72% (109)
9.08% (201)

4.92% (98)
9.17% (202)

White
Black/African-American
Hispanic
American Indian or Alaska Native
Asian
Hawaiin/Pacific Islander
2+ Races

7.41% (256)
7.67% (32)
2.92% (13)
12.12% (4)
10.81% (12)
0.00 % (0)
5.89% (6)

7.11% (250)
7.69% (34)
5.13% (24)
0.00% (0)
6.14% (7)
0.00% (0)
9.00% (9)

10.23% (134)
6.25% (175)

9.77% (136)
5.86% (164)

7.52% (41)
8.88% (82)
8.08% (111)
5.94% (76)

7.49% (494)
8.75% (86)
8.25% (111)
4.80% (66)

Education
Less than High School
High School
Some College
Bachelor’s Degree or Higher
Professional or Doctorate Degree

3.77% (11)
3.82% (47)
8.45% (106)
10.86% (146)
20.16% (26)

3.62% (10)
5.06% (63)
6.37% (81)
10.40% (146)
20.41% (30)

Marital Status
Married
Divorced
Never Married
Living with Partner

8.13% (188)
7.68% (34)
6.17% (52)
7.09% (19)

7.29% (179)
7.46% (37)
7.20% (58)
6.02% (10)

Metro Status
Metro
Non-Metro

7.73% (267)
6.44% (43)

7.39% (265)
5.71% (35)

Overall Awareness (weighted)
Gender

Race

Currently have children under Age 18?
Yes
No
Age

18–29
30–44
45–59
60+
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Percent Who Have Heard of CMV

15

14%

13%

10
7%

9%

9%

7%

7%

6%
5

5%

Women
Adults
Men

0
2007

2010
Year

2013

2016

Figure 1. Percentage of participants in the 2005–2016 HealthStylesTM surveys who reported they had heard of
congenital CMV: for all adults and by gender.
A logistic regression analysis of awareness rates across
years from 2005 – 2016 shows that the decrease in
awareness among U.S. women is statistically significant
(OR = 0.94, 95% CI = [0.93, 0.95], p < .0001). The lack of a
combined rate reported in previous analyses does not allow
for exploration of the statistical significance of the decline of
overall awareness.
CMV awareness was compared to awareness of
other congenital conditions associated with negative
developmental outcomes, up to and including death.
Respondents are least aware of CMV compared to the
10 other conditions. Table 2 presents 2015 and 2016
awareness rates of the 10 comparable conditions to
congenital CMV and the estimated annual frequency, in
number of congenital or infant cases that result in long-term
disabilities for each condition. Figure 2 shows the disparity
between awareness using 2016 results and frequency
of the 11 surveyed conditions. Although other diseases
with low awareness have relatively low occurrences, the
difference between CMV’s relatively high occurrence and
its low awareness is contrasted with Down syndrome,
which has a similar occurrence rate (6,000 babies born
with Down syndrome each year) but 85% to 89% report
awareness of Down syndrome compared to 7% awareness
for CMV.
Table 3 presents the results of each multivariate logistic
regression model, reported as adjusted odds ratios (i.e.,
each odds ratio has been statistically adjusted for all other
variables in the model), and their confidence intervals. In
the first model, which included basic demographic predictor
variables (age, race, gender, education, and household
income), both gender and education level are statistically

significant predictors of CMV awareness. In that model,
women had an odds of awareness of one and a half to
two times greater than men (2015: AOR = 1.56, 95% CI =
[1.22, 2.00], p < .001; 2016: AOR = 1.94, 95% CI = [1.52,
2.51], p < .001) and Hispanic adults (men and women)
were less than half as likely to be aware of CMV as white
adults (2015: AOR = 0.37, 95% CI = [0.19, 0.67], p < .001).
Education also was statistically significantly associated
with awareness about CMV. For each increase in unit of
education, the odds of awareness increased by 1.5 times
(2015: AOR = 1.50, 95% CI = [1.29, 1.74], p < .001; 2016:
AOR = 1.43, 95% CI = [1.23, 1.66], p < .001).
The second model included the presence of children
ages 0–1 or ages 2–5 in the household, which was used
as an indicator of whether the household had recently
experienced a pregnancy. Adding these factors did not
change the relationships seen in Model 1 for either year.
Further, the additional variables (the presence of household
members ages 0–1 or ages 2–5) does not statistically
significantly predict CMV awareness.
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Table 2. Percentage of U.S. Adult Awareness of Childhood Conditions Comparable to Congenital
Cytomegalovirus
2015
Awareness

2016
Awareness

Approximate
Annual U.S.
Frequencya

Congenital Cytomegalovirus (CMV)

6.79%

6.70%

6,000b

Congenital Toxoplasmosis

8.27%

8.53%

400c

Congenital Rubella Syndrome

16.80%

13.27%

< 3d

Beta Strep (Group B Strep)

17.87%

16.91%

380e

Parvovirus B19 (Fifth Disease)

22.52%

19.63%

1045f

Fetal Alcohol Syndrome

65.56%

61.04%

1200g

Spina Bifida

69.42%

64.54%

1500h

Sudden Infant Death Syndrome (SIDS)

83.96%

78.70%

1500i

Autism

88.59%

84.28%

60,000j

Down Syndrome

89.57%

85.44%

6,000k

HIV/AIDS

91.13%

86.33%

30l

Condition

Note. Awareness data taken from the 2015 and 2016 HealthStyles surveys.
a Approximate frequency of infants affected with long-term disabilities, including death, by each condition. b Cannon, M. J.
(2009). Congenital cytomegalovirus (CMV) epidemiology and awareness. Journal of Clinical Virology, 46(Supp. 4), S6–S10.
doi: 10.1016/j.cv.2009.09.002. c Guerina, N. G., Hsu, H. W., Meissner, H. C., Maguire, J. H., Lynfield, R., Stechenberg, B., . .
., The New England Regional Toxoplasma Working Group. (1994, June). Neonatal serologic screening and early treatment
for congenital toxoplasma gondii infection. The New Journal of Medicine, 330(26), 1858–1863. d https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6212a3.htm#fig eGiorgio, E., De Oronzo, M. A., Iozza, I., Di Natale, A., Cianci, S., Garofalo, G., .
. . Politi, S. (2010). Parvovirus B19 during pregnancy: A review. Journal of Prenatal Medicine, 4(4), 63–66. f http://www.cdc.gov/abcs/reports-findings/survreports/gbs10.html g May, P. A., Baete, A., Russo, J., Elliott, A. J., Blankenship, J.,
Kalberg, W. O., . . . Hoyme, H. E. (2014). Prevalence and characteristics of fetal alcohol spectrum disorders. Pediatrics, 134,
855–866. h http://www.cdc.gov/ncbddd/spinabifida/data.html i http://www.cdc.gov/sids/data.htm j http://www.cdc.gov/ncbddd/autism/data.html k http://www.cdc.gov/ncbddd/birthdefects/downsyndrome/data.html l HIV diagnosis at < 1 year,
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6253a1.htm
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6.7%
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8.5%

400

13.3%

Congenital Rubella Syndrome

3

16.9%
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Figure 2. U.S. adult awareness of childhood conditions from the 2016 HealthStylesTM surveys with approximate
annual U.S. incidence of disability due to each condition.
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Table 3. Results of Logistic Regression Analyses Identifying Factors That Do and Do Not Predict CMV Awareness
(2015 and 2016)
Odds Ratio (95% CI)
2015
Model 1a
Gender

Male
Female

Model 2b

2016
Model 1a

Model 2b

1.00 [Reference] 1.00 [Reference] 1.00 [Reference] 1.00 [Reference]
1.56 (1.22, 2.00)* 1.56 (1.22, 2.00)* 1.94 (1.52, 2.51)* 1.94 (1.52, 2.51)*

Education

1.50 (1.29, 1.74)* 1.50 (1.30, 1.74)* 1.43 (1.23, 1.66)* 1.43 (1.23, 1.66)*

Ethnicity
White
Non-Hispanic
Hispanic

1.00 [Reference] 1.00 [Reference] 1.00 [Reference]
0.37 (0.19, 0.67)* 0.37 (0.19, 0.67)* 0.64 (0.40, 1.04)

1.00 [Reference]
0.66 (0.40, 1.03)

Precence of Household
Members age 0-1

0.89 (0.37, 1.82)

1.18 (0.67, 1.98)

Prescence of Household Members age 2-5

1.02 (0.69, 1.46)

1.09 (0.78, 1.48)

Model includes independent variables: age (four categories), gender, education level (less than high school, high school,
some college, bachelor’s degree or higher), household income, race, and ethnicity.
b Model includes independent variables: age (four categories), gender, education level (less than high school, high school,
some college, bachelor’s degree or higher), household income, race, ethnicity, presence of household members ages 0–1,
and presence of household members ages 2–5.
* (p < .001)
a

Table 3 presents the results of each multivariate logistic
regression model, reported as adjusted odds ratios (i.e.,
each odds ratio has been statistically adjusted for all other
variables in the model), and their confidence intervals. In
the first model, which included basic demographic predictor
variables (age, race, gender, education, and household
income), both gender and education level are statistically
significant predictors of CMV awareness. In that model,
women had an odds of awareness of one and a half to
two times greater than men (2015: AOR = 1.56, 95% CI =
[1.22, 2.00], p < .001; 2016: AOR = 1.94, 95% CI = [1.52,
2.51], p < .001) and Hispanic adults (men and women)
were less than half as likely to be aware of CMV as white
adults (2015: AOR = 0.37, 95% CI = [0.19, 0.67], p < .001).
Education also was statistically significantly associated
with awareness about CMV. For each increase in unit of
education, the odds of awareness increased by 1.5 times
(2015: AOR = 1.50, 95% CI = [1.29, 1.74], p < .001; 2016:
AOR = 1.43, 95% CI = [1.23, 1.66], p < .001).
The second model included the presence of children
ages 0–1 or ages 2–5 in the household, which was used
as an indicator of whether the household had recently
experienced a pregnancy. Adding these factors did not
change the relationships seen in Model 1 for either year.
Further, the additional variables (the presence of household
members ages 0–1 or ages 2–5) does not statistically
significantly predict CMV awareness.

Discussion
Awareness of congenital CMV decreased by nearly 50%
from 2010 to 2015 and 2016 despite the large disease
burden and high frequency of infections. The 2015 and
2016 HealthStylesTM survey data showed lower awareness
rates despite increased attention to congenital CMV in the
public health and policy arenas. It is noteworthy that CMV
awareness is even lower than congenital rubella syndrome,
which has been eradicated, and lower than other less
common conditions. Most of the documented efforts by
public health entities to increase CMV awareness (e.g.,
Doutre, 2015; Mirizzi et al., 2015) have taken place since
2013 so it may be too early to see the impact of those
activities, but the fact that CMV awareness appears to be
declining is a serious concern.
Consistent with previous research, analyses of the
HealthStylesTM survey data across multiple years showed
that women are more likely to be aware of CMV than men.
This difference is expected as congenital CMV is most
relevant to pregnant women but the odds ratios of 1.56
(2015) and 1.94 (2016) are lower than desirable in order
to promote prevention of transmission from mother to
fetus during pregnancy. These data suggest that women’s
doctors may not be counseling them on CMV despite its
prevalence and the associated disability burden.
The significance of the differences by demographic factor
are further explored in the logistic regression models. In
addition to CMV awareness being higher among women
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in 2015 and 2016 than for men, CMV also varied by race/
ethnicity. Adult respondents reporting Hispanic ethnicity
reported lower CMV awareness (2.92% in 2015 and 5.13%
in 2016) than adults in general and adults reporting any
other race or ethnicity category. If an adult currently has
children under age 18 he or she is more likely to be aware
of CMV, but awareness in this group remains low (10.23%
in 2015 and 9.77% in 2016).
CMV awareness increases with increasing levels of
education as reported in previous studies. The correlation
of awareness with education level is concerning. Women
with low socioeconomic status have almost three times the
incidence of CMV infection compared to middle income
pregnant women (Johnson et al., 2012) and it appears
that awareness of CMV is often associated with higher
education levels that may not be accessible to women of
lower socioeconomic status. But, even in the most aware
group (those with a professional or doctorate degree,
n = 131), only 20% of the respondents to the 2015 and
2016 HealthStylesTM surveys had heard of CMV. Public
awareness and education initiatives are needed at all
levels.
At the highest risk for CMV infection are parents of
children who have recently had an active infection and are
shedding the virus in bodily fluids (Johnson et al., 2012).
The surrogate measures to this variable are the measures
of adults who report the presence of children ages 0–1 or
the presence of children ages 2–5 in their household. The
presence of children of these ages in the household were
not statistically significantly related to CMV awareness. A
large majority of respondents, 89.5%, did not report having
any children ages 0–1.
Conclusions
Analyses of the 2015 and 2016 HealthStylesTM survey
data shows that awareness of CMV is decreasing among
adults in the United States. Because of the high burden
of disease associated with congenital CMV, it is alarming
that the virus is relatively unknown. There is good evidence
that preventative hygienic measures taken by women and
their partners can reduce the risk of CMV infection and
thus the risk of transmitting CMV to a fetus (Adler and
Nigro, 2013; Revello et al., 2015; Vauloup-Fellous et al.,
2009). A logical precursor to the wider implementation of
preventative hygienic measures is increased awareness of
CMV. Therefore, the decreasing trend in CMV awareness
documented by the HealthStylesTM survey data from 2005
to 2016 is of great concern.
CMV awareness is low for all subsets of the U.S.
population, but it is especially low for Hispanic adults.
Even though awareness is higher for women and those
with higher education levels, awareness in those groups
remains alarmingly low considering CMV’s disease burden
and incidence rate. Furthermore, because CMV can be
transmitted through sexual relations, it is important for men
to be aware of what CMV is and how to prevent it.

The fact that CMV awareness is so low and is decreasing
will hopefully help public health policymakers and program
officials prioritize and focus their efforts to increase CMV
awareness and prevention efforts. The data from the
HealthStylesTM surveys also provide baseline data for
beginning to evaluate CMV public health programs and
specific initiatives, whether mandated by legislation or
prioritized by stakeholders. Continued resources must be
dedicated to increase awareness and prevention of this
harmful virus.
Limitations
The greatest limitation of this study is the narrow definition
of CMV awareness. Survey respondents responded to
one yes/no question: “Have you ever heard of congenital
cytomegalovirus (CMV)?” Ideally, additional questions
would be asked to validate respondents’ awareness of
CMV, such as how CMV is acquired, what the symptoms
of CMV are, what measures may be taken to prevent
CMV, or if there is a CMV vaccine available. Reponses
to these questions would allow policy makers and public
health officials to better target their efforts to increase CMV
awareness and prevention initiatives.
Another limitation of this study was the inability to evaluate
CMV awareness by state and set a baseline for CMV
awareness for states working to increase CMV awareness.
Although state data were provided for each participant,
sample sizes from most states were too small to establish
awareness rates by state. These data would be useful in
planning for CMV awareness programs.
Implications for Further Research
Although the data collected through the HealthStylesTM
survey are useful in establishing the need for CMV
awareness campaigns and education, further research is
needed in many areas related to CMV awareness. First, no
reported research has been conducted on the efficacy of
different methods of raising public awareness and whether
raising awareness of CMV leads to behavior changes in
pregnant women.
Research has established the reasonableness and efficacy
of recommended hygienic measures for reducing risk of
acquiring a CMV infection during pregnancy (Adler and
Nigro, 2013; Revello et al., 2015; Vauloup-Fellous et al.,
2009). However, further research is needed on how to
best educate women about hygienic practices and when is
most appropriate. For example, it would be useful to know
if high school health education programs can effectively
reach women who are just reaching child-bearing age. The
correlation between education level and CMV awareness
suggests a need for further research to study public health
programs including those for high school students and
other young adults. It would be useful to examine high
school and undergraduate health education curriculum
to determine whether information about CMV is currently
included. In addition, further research should be conducted
to determine whether health care providers are informing
women planning to become pregnant and their sexual
partners of CMV.
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Implications for Policy and Public Health Programs
As state EHDI programs, other state agencies, and
non-profit organizations embark on public awareness
programs, consideration should be given to the fact that
CMV awareness seems to be declining. There is a great
need for general awareness and all populations are in
need of education about congenital CMV including low
socioeconomic and Hispanic populations. Consideration
should be given to educating young adults at the beginning
of their childbearing age. Programs should also ensure that
educational materials are available to adults of all races
and ethnicities, especially those with Hispanic ethnicity.
Although women are more likely than men to know about
congenital CMV, it should be the goal of public education
campaigns to raise awareness of both men and women.
Because CMV can be spread through sexual activity
(Fowler & Boppana, 2006; Staras et al., 2006), men should
also be aware of and exercise hygienic precautions during
a partner’s pregnancy to reduce the risk of obtaining a CMV
infection.
CMV awareness rates are alarmingly low and there is a
significant need for CMV education programs. As more
states and other organizations pursue CMV awareness
programs, further work will be needed to establish
measures of the effectiveness of the public health and
policy actions related to CMV. More detailed data, with
larger sample sizes on a local scale, are needed to
evaluate efforts of state stakeholders and non-profit
organizations in developing policy and public information
programs for CMV.
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